论文部分内容阅读
目的:分析胺碘酮与稳心颗粒联合作用在心力衰竭合并心律失常治疗中的有效性。方法:将2015年9月至2016年10月在中山市沙溪隆都医院接受诊治的57例心力衰竭合并心律失常的患者进行分组研究,采用双盲法将患者分为观察组(n=29)和对照组(n=28);两组患者均应用胺碘酮,观察组则联合应用稳心颗粒。结果:在疗效及相关治疗指标上比较,观察组明显占优,差异具有统计学意义(P<0.05);两组患者治疗中均未出现程度较为严重的不良反应,发生率比较,差异均无统计学意义(P>0.05)。结论:胺碘酮联合稳心颗粒治疗心力衰竭合并心律失常,疗效及安全性均较好,效果确切。
Objective: To analyze the effectiveness of amiodarone combined with Wenxin Granule in the treatment of heart failure with arrhythmia. Methods: From September 2015 to October 2016, 57 cases of heart failure with arrhythmia received treatment in Zhongshan Shaxi Longdu Hospital were divided into two groups: the observation group (n = 29) ) And control group (n = 28). Amiodarone was used in both groups, while in observation group, Wenxin Granule was used in combination. Results: Compared with the curative effect and related therapeutic index, the observation group was obviously dominant, the difference was statistically significant (P <0.05). There was no serious adverse reactions in the treatment of both groups, the incidence was no difference Statistical significance (P> 0.05). Conclusion: Amiodarone combined with Wenxin Granule in the treatment of heart failure with arrhythmia has good curative effect and safety, and the effect is exact.